Ingestible capsule that analyzes intestinal fluid in real time is as accurate, faster, and less invasive compared to the current clinical standard.
Small intestinal bacterial overgrowth (SIBO) is a gastrointestinal disease that has clinical overlap with irritable bowel syndrome. Current diagnostic methods are invasive or inaccurate, which often leads to empiric use of antibiotics without a clear diagnosis.
Progenity is developing a novel ingestible diagnostic capsule to address this unmet medical need. It has a built-in assay designed to analyze intestinal fluid samples and transmit data in real time. We sought to determine the accuracy of the capsule’s assay in patients with suspected SIBO.